Coronavirus company news summary – Color receives FDA’s EUA for LAMP technology – Vexos signs agreement for distribution of MVM Ventilators

21 May 2020 (Last Updated May 21st, 2020 09:44)

Pathnostics has launched a Covid-19 polymerase chain reaction (PCR) laboratory test, which is expected to aid the efforts of the US health care workers to ensure the safety of the patients, colleagues and workplaces. The test was developed by the company after its customers said that they needed one which is easy to administer and can identify actively infected Covid-19 patients.

Color has received Emergency Use Authorization (EUA) from the US Food and Drug Administration (FDA) for the use of its LAMP technology for Covid-19 testing. LAMP is a molecular testing technology that offers Covid-19 test results with similar accuracy to the reverse transcription polymerase chain reaction (RT-PCR), but is more suited to high-throughput automation and rapid lab scaleup.

Vexos has signed an exclusive license agreement with Elemaster Group for the manufacturing and distribution of MVM (Mechanical Ventilator Milano) for North, Central and South America. The ventilator was designed and developed to address the needs for the care and recovery for of seriously affected Covid-19 patients. It received the EUA from the FDA on 1 May.

City of Santos in Brazil has deployed Essence SmartCare's advanced senior monitoring technologies with the help of its partner TeleHelp, safeguarding senior citizens and medical staff amid the Covid-19 pandemic. This will reduce the burden on the hospitals and care homes and provide them with home emergency alarms, voice communication, fall detection and activity monitoring. This platform will connect the seniors with 24/7 remote call centres who can carry out a quick emergency response procedures.